VRPX

Virpax Pharmaceuticals, Inc. Common Stock
VRPX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

VRPX was delisted on the 3rd of April, 2025.

Back to rankings

7 hedge funds and large institutions have $34.9K invested in Virpax Pharmaceuticals, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$26.5K
2
+$5.5K
3
+$1.77K
4
SS
SBI Securities
Japan
+$101
5
Bank of America
Bank of America
North Carolina
+$2

Top Sellers

1
-$15.5K
2
-$9K
3
-$9K
4
XT
XTX Topco
Cayman Islands
-$4.77K
5
Morgan Stanley
Morgan Stanley
New York
-$190
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$26.5K
TRCT
2
Tower Research Capital (TRC)
New York
$5.88K
UBS Group
3
UBS Group
Switzerland
$2.4K
SS
4
SBI Securities
Japan
$130
Osaic Holdings
5
Osaic Holdings
Arizona
$10
Bank of America
6
Bank of America
North Carolina
$6
VWM
7
Vermillion Wealth Management
Minnesota
$5
Geode Capital Management
8
Geode Capital Management
Massachusetts
–
HF
9
HRT Financial
New York
–
VF
10
Virtu Financial
New York
–
XT
11
XTX Topco
Cayman Islands
–
Morgan Stanley
12
Morgan Stanley
New York
–